Asymmetrex Provides Scientists At ISSCR 2021 Access To A Missing Critical Quality Attribute For Stem Cell Research and Medicine

Yesterday, June 23, stem cell biotechnology company Asymmetrex presented its latest advances in stem cell technology to attendees in the 2021 Annual Meeting of the International Society for Stem Cell Research, which runs from June 21-26.  The research presentation (Poster #345) highlighted applications in stem cell research and medicine for the company’s first-in-kind technology for quantifying therapeutic

June 24, 2021

Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting

Next week, June 21-26, stem cell biotechnology company Asymmetrex will participate as a presenter and an exhibitor in the 2021 Annual Meeting of the International Society for Stem Cell Research.  In an invited poster presentation (#345) and a company exhibitor display, Asymmetrex will introduce the virtual gathering of international stem cell scientists, physicians, and biotechnologists to

June 17, 2021

Asymmetrex Interviewed by SuperbCrew About Upcoming Presentations at ISSCR 2021

In a June 11 posting, online business and technology news portal SuperbCrew reported their recent interview with Asymmetrex President and CEO James L. Sherley, M.D., Ph.D. about the company’s upcoming first participation in an annual meeting of the International Society for Stem Cell Research. Asymmetrex’s exhibitor display and research poster #345 presentation in the virtual

June 15, 2021

Asymmetrex Discusses a Near Horizon for Stem Cell Dosage in Stem Cell Therapy and Gene Therapy Clinical Trial Supply Chains

Today, May 11, in the Clinical Trial Supply USA 2021 – Virtual Conference, the President and CEO of stem cell biotechnology company Asymmetrex, James L. Sherley, M.D., Ph.D., discussed new developments on the horizon for the supply chains for stem cell therapy and gene therapy clinical trials. In particular, he suggested that it is inevitable

May 13, 2021

Asymmetrex Stem Cell Strains for Immortal DNA Strand Research Featured by Kerafast

Asymmetrex’s latest research report verifying the presence of immortal DNA strands in human tissue stem cells was featured by Kerafast. While other reports have verified immortal DNA strands in stem cells in species such as mold, plants, insects and mice, Asymmetrex’s new study is the first to describe the occurrence of immortal DNA strands in

December 4, 2020

Director James Sherley’s Interview with Superb Crew: Immortality and Stem Cells

Superb Crew interviewed Asymmetrex Director James Sherley to discuss the latest Asymmetrex report of a new advance on stem cell immortality. This interview goes into detail about how stem cell immortality is connected with kinetic stem cell counting, how it will impact the future of kinetic stem cell counting technology, and Asymmetrex’s connection to this

December 2, 2020

Asymmetrex Leads an Online Workshop on Kinetic Tissue Stem Cell Counting for Better Medicines

Asymmetrex has partnered with Proventa International to provide an online workshop on kinetic tissue stem cell counting for better medicine through counting stem cells to improve regenerative and pharmaceutical medicines. The online workshop is on February 18, 2021 at 11AM PST / 2PM EST. In 2020, the FDA’s Standards Coordinating Body (SCB) identified specific counting

November 30, 2020

Asymmetrex Publishes the First Report of Immortal DNA Strands in Human Stem Cells

On November 13, stem cell biotechnology company Asymmetrex published a seminal research report confirming the presence of immortal DNA strands in human tissue stem cells. Immortal DNA strands are the molecular basis for the immortality of tissue stem cells. What does it mean for multiplying cells in the body to be immortal? The cell DNA

November 18, 2020

New Asymmetrex Technologies Featured in RegMedNet

Read Asymmtrex’s latest article in RegMedNet to learn more about its newest technologies, the TORTOISE TestTM and RABBIT CountTM, for analytical and rapid stem cell counting through computing. The TORTOISE TestTM is a tool for tissue stem cell-specific kinetics analyses, and the RABBIT CountTM is a tool for routine rapid tissue stem cell counting. Learn more

October 28, 2020

Asymmetrex Report is the OBM Transplantation Special Issue Cover Story

Asymmetrex recently wrote a report, A Computational Simulation Technology for Specific Counting of Perinatal and Postnatal Human Tissue Stem Cells for Transplantation Medicine, that was published as the cover story in OBM Transplantation Special Issue: Isolation and Characterization of Adult Therapeutic Cells. Read this detailed report to learn more about how the integration of principles

October 19, 2020

Next Page »